Thursday, October 02, 2014 1:11:18 PM
Ratings Breakdown: 1 Sell Rating(s), 4 Buy Rating(s)
Consensus Rating: Buy (Score: 2.60)
Consensus Price Target: $2.10 (255.93% upside)
9/16/2014 Piper Jaffray Reiterated Rating Overweight $1.00 -> $1.20
9/8/2014 Laidlaw Reiterated Rating Buy
8/6/2014 Laidlaw Initiated Coverage Buy $2.50
6/16/2014 ISI Group Initiated Coverage Reduce
10/3/2013 Canaccord Genuity Initiated Coverage Reduce -> Buy $3.00
10/3/2013 Cantor Fitzgerald Initiated Coverage Buy
6/25/2013 Piper Jaffray Initiated Coverage Overweight
4/2/2013 JMP Securities Initiated Coverage Outperform $2.00
Recent MSTX News
- NYSE and Nasdaq Pull ETF Options Requests, 75% of Bitcoins Remain Inactive, MakerDAO Halts WBTC Loans • IH Market News • 08/16/2024 07:25:47 PM
- Deutsche Bank Faces Shareholder Backlash, Bank of America Sponsors 2026 World Cup, Quanterix CEO Buys More Shares • IH Market News • 08/16/2024 10:03:21 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM